Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study. Diabetologia. 2023 Oct;66(10):1908-1913. doi: 10.1007/s00125-023-05971-y. Epub 2023 Jul 28. PMID: 37505281.